DRD2 and Parkinson disease: A2AR antagonists have been shown to be beneficial in various animal models of PD (e.g., D2R knockout mice [153], 6-OHDA-lesioned rats [154,155] and mice [156], rats with pharmacological D2R blockade [157], MPTP-treated marmosets [158], and MPTP-treated monkeys [159]).